Gilead Sciences (GILD) Gross Profit (2009 - 2026)
Gilead Sciences' (GILD) quarterly Gross Profit came in at $5.5 billion in Q1 2026, up 7.57% YoY from $5.1 billion in Q1 2025, and down 12.47% on a QoQ basis from $6.3 billion in Q4 2025.
Gilead Sciences (GILD) Gross Profit (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of Gross Profit data on file, last reported at $5.5 billion in Q1 2026.
- Quarterly Gross Profit rose 7.57% year-over-year to $5.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.6 billion (up 4.89% YoY) and the FY2025 annual result came in at $23.2 billion, up 3.14% from the prior year.
- Gross Profit fell to $5.5 billion in Q1 2026, from $6.3 billion in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $6.3 billion in Q4 2025 to a low of $4.8 billion in Q2 2022.
- A 5-year average of $5.5 billion and a median of $5.5 billion in 2023 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit grew 29.8% — and 2023, when it declined 16.17%.
- Tracing GILD's Gross Profit over 5 years: stood at $6.0 billion in 2022, then decreased by 16.17% to $5.0 billion in 2023, then rose by 19.19% to $6.0 billion in 2024, then rose by 5.23% to $6.3 billion in 2025, then slipped by 12.47% to $5.5 billion in 2026.
- The last three Gross Profit figures came in at $5.5 billion (Q1 2026), $6.3 billion (Q4 2025), and $6.2 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|